agilon health vs Privia Health
AGL and PRVA side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AGL and PRVA compare
Privia Health is the larger company, worth 1.6 times as much as agilon health ($3.1B against $1.9B).
Privia Health grew revenue faster over the last twelve months (19.2% versus 2.0% for agilon health).
Privia Health keeps more of each dollar of sales as profit, with a net margin of 1.4% compared with −1.5% at agilon health.
Privia Health scores higher on the StockData Score (15 against 4 for agilon health), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AGL | PRVA |
|---|---|---|
| Size and price | ||
| Market cap | $1.9B | $3.1B |
| Share price | $114.81 | $24.04 |
| Change, 1 year | 596% | 2.7% |
| Change, 5 years | −80.7% | −16.7% |
| Beta (5Y) | 1.28 | 0.65 |
| Employees | 856 | 1,226 |
| StockData Score | ||
| Total score | 4 | 15 (better) |
| Valuation score | 1 | 2 (better) |
| Growth score | 1 | 3 (better) |
| Performance score | 1 | 4 (better) |
| Health score | 1 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 92.5× |
| P/S | 0.3× (better) | 1.3× |
| P/B | – | 3.8× |
| EV/EBITDA | – | 42.0× |
| FCF yield | −0.88% | – |
| Fair value | – | $15.41 |
| Margin of safety | – | −56.0% |
| Growth | ||
| Revenue growth (TTM) | 2.0% | 19.2% (better) |
| Revenue growth, 5Y average | 37.2% (better) | 21.0% |
| Net income growth (TTM) | – | 91.3% |
| EPS growth (TTM) | – | 100% |
| EPS growth, 5Y average | – | −11.4% |
| Profitability | ||
| Operating margin | −2.6% | 2.1% (better) |
| Net margin | −1.5% | 1.4% (better) |
| FCF margin | −0.28% | – |
| Return on equity | – | 4.6% |
| Return on invested capital | – | 10.0% |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Interest coverage | −22.4× | – |
| Current ratio | 1.13 | 1.63 (better) |
| Altman Z-score | 2.86 | 4.54 (better) |
| Piotroski F-score | 2 | 6 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 95.8% | 96.7% |
| Held by insiders | 10.1% | 7.1% |
| Insider net buying, 12 months | $300K (better) | −$22.2M |
| Superinvestors holding | 1 | 1 |
| Short interest, % of float | 5.6% | 3.3% |
Go deeper
- AGL stock overview
- AGL income statement
- AGL valuation and score
- PRVA stock overview
- PRVA income statement
- PRVA valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.